NIHR to invest £59m in AMR, air pollution and infectious diseases
The National Institute for Health Research (NIHR) has announced plans to invest £58.7 million in to research to protect the public from health threats such as antimicrobial resistance (AMR), air pollution and infectious diseases.
The new cash injection will go towards 14 new NIHR Health Protection Research Units (HPRUs), which in turn will fund high quality research that enhances the ability of Public Health England (PHE) to use “innovative techniques” to protect the public’s health and “minimise the health impact of emergencies.”
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
